Nanoparticle-mediated endothelial cell-selective drug delivery system

Kaku Nakano, Jun Ichiro Koga, Kensuke Egashira

    Research output: Chapter in Book/Report/Conference proceedingChapter

    1 Citation (Scopus)

    Abstract

    Peripheral arterial disease (PAD) causes peripheral tissue ischemia, resulting in skin ulceration, gangrene, and limb amputation. The therapeutic goal is restoration of blood supply, and various treatments including exercise, medical therapy, and surgical revascularization are performed. The prognosis of critical limb ischemia, however, is still unsatisfactory, and there are unmet needs in developing novel therapeutics. We have been developing novel nanotechnology-based drug delivery system aiming efficient angiogenesis by delivering of HMG-CoA reductase inhibitor (statin) to endothelium. In this chapter, we summarized current developing status of nanotechnology-based drug delivery system including animal experiments and ongoing clinical trials (CLINICAL TRIAL REGISTRATION NUMBER: UMIN000008011).

    Original languageEnglish
    Title of host publicationTherapeutic Angiogenesis
    PublisherSpringer Singapore
    Pages247-266
    Number of pages20
    ISBN (Electronic)9789811027444
    ISBN (Print)9789811027437
    DOIs
    Publication statusPublished - Jul 11 2017

    All Science Journal Classification (ASJC) codes

    • Engineering(all)
    • Computer Science(all)

    Fingerprint Dive into the research topics of 'Nanoparticle-mediated endothelial cell-selective drug delivery system'. Together they form a unique fingerprint.

    Cite this